Invention Grant
US09550756B2 Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
有权
哒嗪酮化合物作为磷酸二酯酶抑制剂和治疗疾病的方法
- Patent Title: Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
- Patent Title (中): 哒嗪酮化合物作为磷酸二酯酶抑制剂和治疗疾病的方法
-
Application No.: US14517313Application Date: 2014-10-17
-
Publication No.: US09550756B2Publication Date: 2017-01-24
- Inventor: Takahiko Taniguchi , Jun Kunitomo , Masato Yoshikawa , Makoto Fushimi
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Main IPC: A61K31/501
- IPC: A61K31/501 ; C07D403/04 ; C07D403/14 ; C07D401/14 ; C07D405/04 ; C07D405/14 ; C07D409/04 ; C07D409/14 ; C07D413/04 ; C07D413/14 ; A61K9/20
Abstract:
The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on.A compound of formula (I0): wherein R1 represents a substituent, R2 represents a hydrogen atom, or a substituent, R3 represents a hydrogen atom, or a substituent, Ring A represents an aromatic ring which can be substituted, and Ring B represents a 5-membered heteroaromatic ring which can be substituted, or a salt thereof.
Public/Granted literature
- US20150099757A1 PYRIDAZINONE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS AND METHODS OF TREATING DISORDERS Public/Granted day:2015-04-09
Information query
IPC分类:
